GNS Genus Plc

    RNS Number : 1298Z
  Genus PLC
  16 July 2008
   

    For Immediate Release                                                                     16 July 2008   


    GENUS plc
    ("Genus" or "the Company")

    Pre-Close Trading Update


    Genus, a leading global animal genetics company, today issues an update on trading for the six months to 30 June 2008.

    Genus has continued to trade in line with the Board's expectations and has successfully offset the impact of exceptionally high global
animal feed prices with the increased international spread of its business and improved efficiencies. The Board therefore remains confident
in the outlook for the future. 

    Genus will announce its Preliminary Results on 16 September 2008.


    For further information please contact:

    Genus plc                                            Tel: 01256 345970
    Richard Wood, Chief Executive
    Martin Boden, Finance Director

    Buchanan Communications                Tel: 0207 466 5000
    Charles Ryland
    Suzanne Brocks

    This announcement is available on the Genus website, www.genusplc.com


    About Genus:

    Genus sells added value products for livestock farming and food producers by creating advances to animal breeding through biotechnology.
Its non-genetically modified organism technology is applicable across all livestock species but is only commercialised by Genus in the
bovine and porcine farming sectors.

    Genus' worldwide sales are made in seventy countries under the trade marks "ABS" (dairy and beef cattle) and "PIC" (pigs) and comprise
semen and breeding animals with superior genetics to those animals currently in production. Customers use Genus genetics in their herds to
produce offspring with greater production efficiency, milk and meat output and quality. These offspring are used to supply the global dairy
and meat supply chains.

    Genus' competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used
to improve them and the Group's global production and distribution network.

    Headquartered in Basingstoke, England, Genus companies operate in 30 countries on six continents, with research laboratories located in
Madison, Wisconsin, USA. 


This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
TSTEALXSFLSPEFE

Genus (LSE:GNS)
Historical Stock Chart
From Aug 2024 to Sep 2024

Genus (LSE:GNS)
Historical Stock Chart
From Sep 2023 to Sep 2024